Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $22.62M | $0.54 | $13.00 | 2,307.41% | Strong Buy | 2 | N/A | N/A | -5,552.75% | -343.38% | |||
| KALA | KALA BIO INC | $9.94M | $1.54 | $32.67 | 2,021.23% | Buy | 3 | N/A | N/A | -893.03% | -105.64% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $7.23M | $4.56 | $95.50 | 1,994.30% | Buy | 2 | N/A | N/A | -1,395.33% | -808.10% | |||
| ATYR | ATYR PHARMA INC | $63.19M | $0.71 | $13.63 | 1,819.01% | Buy | 4 | N/A | N/A | 21.74% | 16.78% | |||
| MRSN | MERSANA THERAPEUTICS INC | $39.93M | $8.00 | $140.00 | 1,650.00% | Strong Buy | 2 | 12.06% | N/A | N/A | -12.89% | |||
| FEMY | FEMASYS INC | $11.30M | $0.42 | $7.00 | 1,586.75% | Strong Buy | 2 | 159.81% | N/A | -122.78% | -18.46% | |||
| GOVX | GEOVAX LABS INC | $14.07M | $0.56 | $8.50 | 1,431.53% | Strong Buy | 2 | N/A | N/A | 4,539.42% | 2,393.57% | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $81.60M | $4.62 | $61.50 | 1,231.17% | Strong Buy | 4 | N/A | N/A | 796.95% | 436.51% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $29.06M | $0.51 | $6.50 | 1,187.13% | Buy | 2 | 299.93% | N/A | N/A | -188.43% | |||
| FGEN | FIBROGEN INC | $48.24M | $11.93 | $146.50 | 1,128.00% | Buy | 2 | N/A | N/A | N/A | -19.10% | |||
| NRXP | NRX PHARMACEUTICALS INC | $65.62M | $3.33 | $40.00 | 1,101.20% | Strong Buy | 3 | N/A | N/A | -276.64% | 2,036.49% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $211.20M | $0.70 | $8.33 | 1,090.43% | Strong Buy | 3 | 8.11% | N/A | 92.35% | 18.56% | |||
| PSTV | PLUS THERAPEUTICS INC | $67.70M | $0.68 | $7.88 | 1,054.69% | Strong Buy | 4 | 41.35% | N/A | 359.89% | 105.50% | |||
| GRI | GRI BIO INC | $4.96M | $1.97 | $22.50 | 1,042.13% | Buy | 2 | N/A | N/A | -26.50% | -15.51% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $38.43M | $2.64 | $26.67 | 910.11% | Buy | 3 | 405.49% | N/A | N/A | N/A | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.52M | $4.96 | $50.00 | 908.06% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.81M | $1.04 | $10.00 | 861.54% | Strong Buy | 2 | N/A | N/A | -71.37% | -60.18% | |||
| MDCX | MEDICUS PHARMA LTD | $44.72M | $2.51 | $23.50 | 836.25% | Strong Buy | 2 | N/A | N/A | -82.26% | -22.39% | |||
| LSTA | LISATA THERAPEUTICS INC | $21.93M | $2.55 | $23.50 | 821.57% | Strong Buy | 2 | 240.34% | N/A | -33.23% | -29.08% | |||
| MTVA | METAVIA INC | $23.76M | $0.98 | $9.00 | 816.50% | Strong Buy | 3 | N/A | N/A | -279.09% | -145.51% | |||
| KAPA | KAIROS PHARMA LTD | $23.86M | $1.15 | $10.50 | 813.04% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $21.97M | $4.06 | $36.50 | 799.01% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| CRDL | CARDIOL THERAPEUTICS INC | $86.81M | $1.05 | $9.00 | 757.14% | Buy | 2 | N/A | N/A | 158.27% | 93.74% | |||
| MYO | MYOMO INC | $34.66M | $0.92 | $7.83 | 754.20% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.50M | $5.39 | $45.00 | 734.88% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| INTS | INTENSITY THERAPEUTICS INC | $12.71M | $0.27 | $2.25 | 733.33% | Strong Buy | 2 | N/A | N/A | -517.12% | -254.19% | |||
| JSPR | JASPER THERAPEUTICS INC | $39.33M | $2.42 | $20.14 | 732.36% | Buy | 7 | N/A | N/A | -387.30% | -195.88% | |||
| SLN | SILENCE THERAPEUTICS PLC | $245.37M | $5.20 | $42.60 | 719.23% | Buy | 5 | 8.38% | N/A | N/A | -94.33% | |||
| IPSC | CENTURY THERAPEUTICS INC | $43.02M | $0.50 | $4.00 | 703.21% | Strong Buy | 2 | N/A | N/A | -40.33% | -29.74% | |||
| MBRX | MOLECULIN BIOTECH INC | $15.14M | $0.50 | $4.00 | 700.00% | Buy | 2 | N/A | N/A | N/A | -67.32% | |||
| NOTE | FISCALNOTE HOLDINGS INC | $71.32M | $4.97 | $37.50 | 654.53% | Strong Buy | 2 | -11.65% | N/A | -33.81% | -11.15% | |||
| PMN | PROMIS NEUROSCIENCES INC | $24.25M | $0.47 | $3.50 | 647.86% | Strong Buy | 2 | N/A | N/A | -2,302.04% | 92.61% | |||
| PASG | PASSAGE BIO INC | $25.59M | $8.05 | $59.25 | 636.02% | Strong Buy | 4 | N/A | N/A | -8.89% | -4.29% | |||
| IMUX | IMMUNIC INC | $92.27M | $0.96 | $7.00 | 626.90% | Strong Buy | 4 | N/A | N/A | N/A | -200.84% | |||
| TIL | INSTIL BIO INC | $118.48M | $17.55 | $125.00 | 612.25% | Buy | 2 | N/A | N/A | -32.66% | -18.62% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.86M | $9.40 | $65.00 | 591.49% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ACET | ADICET BIO INC | $68.48M | $0.83 | $5.50 | 564.25% | Strong Buy | 2 | N/A | N/A | -47.64% | -40.22% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $33.19M | $0.49 | $3.20 | 555.74% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.89M | $5.32 | $34.75 | 553.20% | Strong Buy | 2 | 17.65% | N/A | -2.15% | -1.01% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $118.84M | $0.92 | $5.88 | 538.59% | Buy | 2 | N/A | N/A | -51.49% | -46.05% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $286.23M | $1.29 | $8.00 | 520.16% | Strong Buy | 7 | N/A | N/A | -46.15% | -33.79% | |||
| ANVS | ANNOVIS BIO INC | $43.45M | $2.23 | $13.50 | 505.38% | Strong Buy | 2 | N/A | N/A | -160.52% | -137.15% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.